704 resources
Rows 0 - 200 Next
| Package | Identity | Name/Title | Status | FMM | WG | Date | Source(s) |
|---|---|---|---|---|---|---|---|
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.27--20170503000000 | Medicine Package | draft | 2024-08 | |||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.60--20171214102248 | Allergy-intolerance Criticality | draft | 2024-08 | oid | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.58--20171212193352 | Topographical modifier (qualifier) | draft | 2024-08 | sct | ||
| hl7.fhir.uv.saner | DecadeAgeBrackets | Age Brackets By Decade | active | pher | 2024-05 | fhir | |
| hl7.fhir.uv.saner | ScoreAgeBrackets | Age Brackets By Score (20) | active | pher | 2024-05 | fhir | |
| hl7.fhir.uv.termchangeset | update-methods-valueset | Terminology Server Update Methods ValueSet | draft | 0 | vocab | 2025-08 | fhir |
| hl7.fhir.uv.phd | SimpleAlertOperationalStates | Simple Alert Operational States | trial-use | 1 | dev | 2025-08 | fhir |
| hl7.fhir.uv.genomics-reporting | variant-confidence-status-vs | Variant Confidence Status | trial-use | 2 | cg | 2025-06 | tho |
| hl7.fhir.uv.cardx-htn-mng | smbp-obs-status | SMBP Observation Status value set | draft | cic | 2024-12 | fhir | |
| example.fhir.uv.myig | valueset-fake | ValueSet fake | informative | 2015-06 | internal | ||
| example.fhir.uv.myig | valueset-no-codesystem | ValueSet with no code-system | informative | 2015-06 | |||
| hl7.fhir.uv.vhdir | digitalcertificatetrustframework | VhDir Digital Certificate Trust Framework Value Set | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.cpg | cpg-activity-type-vs | CPG Activity Type Value Set | active | cds | 2024-11 | fhir | |
| hl7.fhir.uv.cpg | cpg-casefeature-pertinence-vs | CPG Case Feature Pertinence Value Set | active | cds | 2024-11 | fhir | |
| hl7.fhir.uv.cpg | cpg-casefeature-type-vs | CPG Case Feature Type Value Set | active | cds | 2024-11 | fhir | |
| HIE2.packages | results-laboratory-blood-abo-rh-grp-gps-uv-ips | Results Laboratory ABO+RH Group (GPS) - IPS | active | 2022-01 | sct | ||
| HIE2.packages | absent-or-unknown-allergies-uv-ips | Absent or Unknown Allergies - IPS | active | 2022-01 | fhir | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.61--20180127221947 | Absent or Unknown Devices | draft | 2024-08 | fhir | ||
| HIE2.packages | absent-or-unknown-immunizations-uv-ips | Absent or Unknown Immunization - IPS | active | 2022-01 | fhir | ||
| HIE2.packages | absent-or-unknown-medications-uv-ips | Absent or Unknown Medication - IPS | active | 2022-01 | fhir | ||
| HIE2.packages | absent-or-unknown-problems-uv-ips | Absent or Unknown Problems - IPS | active | 2022-01 | fhir | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.22--20170502000000 | ActStatusActiveCompletedAbortedCancelled | draft | 2024-08 | tho | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.12--20170330000000 | ActStatusActiveCompletedAbortedSuspended | draft | 2024-08 | tho | ||
| hl7.fhir.uv.cpg | cpg-active-condition-vs | CPG Active Condition Value Set | active | cds | 2024-11 | tho | |
| hl7.fhir.uv.saner | MeasureScoring | Measure Scoring | active | pher | 2024-05 | fhir | |
| hl7.fhir.uv.cqm | iso-8601-derived-periods | ISO-8601-Derived Periods | trial-use | 4 | cqi | 2025-06 | tho |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.2--20161206000000 | Allergy or Intolerance Type | draft | 2024-08 | tho oid | ||
| hl7.fhir.uv.saner | MeasureStatus | Measure Status Values | active | pher | 2024-05 | fhir | |
| hl7.fhir.uv.livd | livd-bundle-type | Allowed types of bundles for the LIVD catalog | trial-use | 2 | oo | 2019-07 | fhir |
| hl7.fhir.uv.sdc | sdc-question-library-states | Australian States - example value set | active | fhir | 2025-08 | fhir | |
| hl7.fhir.uv.vulcan-rwd | ExampleAntiTNFADrugCodes | AntiTNFA Example Drug Codes | active | 2023-05 | example | ||
| hl7.fhir.uv.vulcan-rwd | ExampleACSConditionCodes | ACS Example Condition Codes | active | 2023-05 | icd | ||
| hl7.fhir.uv.vulcan-rwd | ExampleCrohnsDiseaseConditionCodes | AntiTNFA Example Condition Codes | active | 2023-05 | icd | ||
| hl7.fhir.uv.vulcan-rwd | ExampleDiabetesConditionCodes | Diabetes Example Condition Codes | active | 2023-05 | icd | ||
| hl7.fhir.uv.vulcan-rwd | ExampleRespiratoryConditionCodes | Covid-19 Example Condition Codes | active | 2023-05 | sct icd | ||
| hl7.fhir.uv.vulcan-rwd | ExampleHbA1cTestCodes | Diabetes Example Test Codes | active | 2023-05 | loinc | ||
| hl7.fhir.uv.vulcan-rwd | ExampleCOVID19TestCodes | Covid-19 Example Test Codes | active | 2023-05 | loinc | ||
| hl7.fhir.uv.vulcan-rwd | ExampleDialysisProcedureCodes | Diabetes Example Dialysis Test Codes | active | 2023-05 | sct | ||
| hl7.fhir.uv.vulcan-rwd | ExampleClopidogrelCodes | ACS Example Clopidogrel Codes | active | 2023-05 | rx ndc | ||
| hl7.fhir.uv.vulcan-rwd | ExamplePrasugrelCodes | ACS Example Prasugrel Codes | active | 2023-05 | rx ndc | ||
| hl7.fhir.uv.vulcan-rwd | ExampleTicagrelorCodes | ACS Example Ticagrelor Codes | active | 2023-05 | rx ndc | ||
| hl7.fhir.uv.vulcan-rwd | ExampleACSOralAntiplatelets | ACS Example Oral Antiplatelet Drug Codes | active | 2023-05 | fhir | ||
| hl7.fhir.uv.vulcan-rwd | ExampleNonBNT162b2Codes | Covid-19 Example Vaccine Codes | active | 2023-05 | cvx | ||
| hl7.fhir.uv.vhdir | primarysourcevalidationprocess | VhDir Primary Source Validation Process | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | validationneed | VhDir Primary Source Validation Need | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | externalvalidationtype | VhDir External Validation Type Value Set | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.genomics-reporting | genomic-study-change-type-vs | Genomic Study Change Type ValueSet | trial-use | 2 | cg | 2025-06 | fhir |
| hl7.fhir.uv.genomics-reporting | genomic-study-data-format-vs | Genomic Study Data Format ValueSet | trial-use | 2 | cg | 2025-06 | fhir |
| hl7.fhir.uv.genomics-reporting | genomic-study-method-type-vs | Genomic Study Method Type ValueSet | trial-use | 2 | cg | 2025-06 | fhir |
| hl7.fhir.uv.genomics-reporting | genomic-study-status-vs | Genomic Study Status ValueSet | trial-use | 2 | cg | 2025-06 | fhir |
| hl7.fhir.uv.genomics-reporting | genomic-study-type-vs | Genomic Study Type ValueSet | informative | cg | 2025-06 | fhir | |
| hl7.fhir.uv.crmi | crmi-release-experimental-behavior | CRMI Release Experimental Behavior | trial-use | 2 | cds | 2025-08 | fhir |
| hl7.fhir.uv.crmi | crmi-release-version-behavior | CRMI Release Version Behavior | trial-use | 2 | cds | 2025-08 | fhir |
| hl7.fhir.uv.lab-report | laterality-uv-lab | Body Structure Laterality | trial-use | 2 | oo | 2025-01 | sct |
| hl7.fhir.uv.lab-report | siteQualifier-uv-lab | Body Structure Qualifier | trial-use | 2 | oo | 2025-01 | sct |
| hl7.fhirpath | calendar-units | Calendar Duration Units ValueSet | active | 2024-02 | fhir | ||
| hl7.fhir.uv.smart-app-launch | user-access-category | User Access Category Value Set | active | fhir | 2023-03 | tho | |
| hl7.fhir.uv.eyecare | conditions | Ophthalmology Condition ICD10 and SNOMED codes ValueSet | active | 2019-05 | sct icd | ||
| hl7.fhir.uv.pocd | operating-mode | Operating Mode | draft | 2020-05 | fhir | ||
| hl7.fhir.uv.pocd | kind-of-relation | Kind | draft | 2020-05 | fhir | ||
| hl7.fhir.uv.pocd | safety | Safety | draft | 2020-05 | fhir | ||
| hl7.fhir.uv.pocd | metric-availability | Metric Availability | draft | 2020-12 | fhir | ||
| hl7.fhir.uv.saner | ConfirmedCOVID19Diagnoses | Confirmed COVID-19 Diagnosis Values | active | pher | 2024-05 | sct icd | |
| hl7.fhir.uv.termchangeset | designation-acceptability-vs | Designation Acceptability Value Set | draft | 0 | vocab | 2025-08 | sct |
| hl7.fhir.uv.termchangeset | case-significance-vs | Case Significance Value Set | draft | 0 | vocab | 2025-08 | sct |
| hl7.fhir.uv.termchangeset | defining-relationship-type-vs | Defining Relationship Type Value Set | draft | 0 | vocab | 2025-08 | sct |
| hl7.fhir.uv.termchangeset | el-profile-set-operator-vs | EL Profile Set Operator Value Set | draft | 0 | vocab | 2025-08 | sct |
| hl7.fhir.uv.saner | Covid19Labs | COVID-19 Diagnostic Test | active | pher | 2024-05 | fhir loinc | |
| hl7.fhir.uv.saner | NegativeResults | COVID-19 Not Detected | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | PositiveResults | COVID-19 Detected | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.vhdir | usecasetype | VhDir Use Case Type | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | accessibility | VhDir Accessibility Value Set | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | network-type | VhDir Network Type Value Set | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | patientaccess | VhDir Ehr Patient Access Value Set | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | identifier-type | VhDir Identifier Type Value Set | trial-use | 2 | pa | 2018-02 | tho |
| hl7.fhir.uv.vhdir | languageproficiency | VhDir Spoken Language Proficiency | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | certificationedition | VhDir Certification Edition Value Set | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | aliastype | VhDir Alias Type Value Set | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | qualificationstatus | VhDir Qualification Status | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | identifierstatus | VhDir Identifier Status Value Set | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.vhdir | consent | VhDir Consent Value Set | trial-use | 2 | pa | 2018-02 | fhir tho |
| hl7.fhir.uv.saner | AllCOVID19RiskFactors | All COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | COPDCOVID19RiskFactors | COPD COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | CardiovascularCOVID19RiskFactors | Cardiovascular COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | KidneyDiseaseCOVID19RiskFactors | Kidney Disease COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | DiabetesCOVID19RiskFactors | Diabetes COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | HypertensionCOVID19RiskFactors | Hypertension COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | NeoplasticCOVID19RiskFactors | Neoplastic COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | ObesityCOVID19RiskFactors | Obesity COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | PregnancyCOVID19RiskFactors | Pregnancy COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | SickleCellCOVID19RiskFactors | Sickle Cell COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | TobaccoCOVID19RiskFactors | Tobacco COVID-19 Risk Factors | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | COVID19Complications | COVID-19 Complications | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | VTEReports | Codes for reports about VTE Diagnosics | active | pher | 2024-05 | loinc | |
| hl7.fhir.uv.saner | IsolationPrecautions | COVID-19 Isolation Precautions | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | SuspectedOrConfirmedCOVID19Diagnoses | Suspected Or Diagnosed COVID-19 | active | pher | 2024-05 | sct icd | |
| hl7.fhir.uv.ae-research-backport-ig | adverse-event-status-vs | Adverse Event Status | informative | brr | 2024-04 | fhir | |
| hl7.fhir.uv.cql | anc-b5-de51 | Example Danger Signs - Central cyanosis Codes | draft | 2025-07 | fhir | ||
| hl7.fhir.uv.crmi | anc-b5-de51 | Danger Signs - Central cyanosis Codes (Example) | draft | 2025-08 | fhir | ||
| hl7.fhir.uv.cql | anc-b5-de49 | Example Danger Signs - No danger signs Codes | draft | 2025-07 | fhir | ||
| hl7.fhir.uv.crmi | anc-b5-de49 | Danger Signs - No danger signs Codes (Example) | draft | 2025-08 | fhir | ||
| hl7.fhir.uv.cql | anc-b5-de50 | Example Danger signs Codes | draft | 2025-07 | fhir | ||
| hl7.fhir.uv.crmi | anc-b5-de50 | Danger signs Codes (Example) | draft | 2025-08 | fhir | ||
| hl7.fhir.uv.cql | shareable-example | Example Specific health concern(s) Codes | draft | 2025-07 | fhir | ||
| hl7.fhir.uv.crmi | shareable-example | Specific health concern(s) Codes (Shareable Example) | draft | 2025-08 | fhir | ||
| hl7.fhir.uv.termchangeset | dialect-vs | Dialect Value Set | draft | 0 | vocab | 2025-08 | sct |
| hl7.fhir.uv.termchangeset | changetype-vs | Change Type Value Set | draft | 0 | vocab | 2025-08 | tho |
| hl7.fhir.uv.sdc | questionnaire-answer-constraint | Questionnaire answer constraints value set | trial-use | 4 | fhir | 2025-08 | fhir |
| hl7.fhir.uv.cpg | anc-reason-for-visit-vs | ANC Reason for Visit ValueSet | active | cds | 2024-11 | fhir | |
| hl7.fhir.uv.phenomics-exchange | DiagnosticMarker | Diagnostic Marker | draft | cic | 2020-02 | ncit | |
| hl7.fhir.uv.phenomics-exchange | TumorProgression | Tumor Progression | draft | cic | 2020-02 | ncit | |
| hl7.fhir.uv.phenomics-exchange | TumorGrade | Tumor Grade | draft | cic | 2020-02 | ncit | |
| hl7.fhir.uv.phenomics-exchange | TumorStage | Tumor Stage | draft | cic | 2020-02 | ncit | |
| hl7.fhir.uv.saner | ICULocations | ICU Locations | active | pher | 2024-05 | cdc | |
| hl7.fhir.uv.saner | VentilatorDevices | Ventilator Devices | active | pher | 2024-05 | sct | |
| hl7.fhir.uv.saner | InpatientLocations | Inpatient Locations | active | pher | 2024-05 | cdc | |
| hl7.fhir.uv.saner | PatientDeaths | Patient Died | active | pher | 2024-05 | tho | |
| hl7.fhir.uv.saner | VentilatorProcedures | Ventilator Procedures | active | pher | 2024-05 | sct cpt | |
| hl7.fhir.uv.saner | VentilatorObservations | Ventilator Observations | active | pher | 2024-05 | loinc | |
| hl7.fhir.uv.cpg | cpg-common-persona-vs | CPG Common Persona Value Set | active | cds | 2024-11 | fhir | |
| hl7.fhir.uv.cpg | cpg-common-process-vs | CPG Common Process Value Set | active | cds | 2024-11 | fhir | |
| hl7.fhir.uv.eyecare | observable-entities | Ophthalmology observations (SNOMED) | active | 2019-05 | sct | ||
| hl7.fhir.uv.shc-vaccination | completed-observation-status | Completed observation status | draft | pher | 2024-12 | fhir | |
| hl7.fhir.uv.genomics-reporting | dna-change-type-vs | DNA Change Type | trial-use | 2 | cg | 2025-06 | |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.14--20170401000000 | DRUGActCode | draft | 2024-08 | tho | ||
| hl7.fhir.uv.smart-app-launch | smart-launch-types | Launch Types for tasks to application launches | active | fhir | 2024-05 | fhir | |
| hl7.fhir.uv.sdc | assemble-expectation | Questionnaire Assemble Expectation | trial-use | 4 | fhir | 2025-08 | fhir |
| hl7.fhir.uv.smart-app-launch | smart-launch-info | Codes for tasks to application launches | active | fhir | 2024-05 | fhir | |
| hl7.fhir.uv.sdc | formBehaviorConditions | Questionnaire Form Behavior Conditions | informative | fhir | 2025-08 | fhir | |
| hl7.fhir.uv.sdc | entryMode | Questionnaire Entry Mode | trial-use | 4 | fhir | 2025-08 | fhir |
| hl7.fhir.uv.sdc | collapsible | Questionnaire Item Collapsible | trial-use | 4 | fhir | 2025-08 | fhir |
| hl7.fhir.uv.sdc | observation-extract-relationship | Observation Extract Relationship Value Set | trial-use | 4 | fhir | 2025-08 | fhir |
| hl7.fhir.uv.phenomics-exchange | geno-ontology-allelic-state-vs | GENO Ontology Allelic State Value Set | draft | cic | 2024-06 | gene | |
| hl7.fhir.uv.phenomics-exchange | sequence-ontology-structural-variant-vs | Sequence Ontology Structural Variant Value Set | draft | cic | 2024-06 | ||
| hl7.fhir.uv.phenomics-exchange | moleculeContext-vs | Molecule Context Value Set | draft | cic | 2024-06 | ||
| hl7.fhir.uv.phenomics-exchange | acmgPathogenicityClassification-vs | ACMG Pathogenicity Classification Value Set | draft | cic | 2024-06 | ||
| hl7.fhir.uv.phenomics-exchange | interpretationStatus-vs | Interpretation Status Value Set | draft | cic | 2024-06 | ||
| hl7.fhir.uv.eyecare | body-site-eye | Ophthalmic anatomical location | active | 2021-08 | sct | ||
| hl7.fhir.uv.phenomics-exchange | therapeuticActionability-vs | Therapeutic Actionability Value Set | draft | cic | 2024-06 | ||
| hl7.fhir.uv.eyecare | observation-visual-acuity-methods | Visual acuity chart valueset (SNOMED) | active | 2019-05 | sct | ||
| hl7.fhir.uv.eyecare | iop-methods | Intraocular pressure (IOP) method valueset | active | 2019-05 | sct tho | ||
| hl7.fhir.uv.eyecare | observation-visual-acuity | Visual acuity method valueset (SNOMED) | active | 2019-05 | sct | ||
| hl7.fhir.uv.eyecare | observation-final-status | Observation Status | active | 2021-07 | fhir | ||
| hl7.fhir.uv.eyecare | qualifiers | Ophthalmic anatomical location qualifiers | active | 2019-05 | sct tho | ||
| hl7.fhir.uv.vhdir | validationprocess | VhDir Validation Process | trial-use | 2 | pa | 2018-02 | fhir |
| hl7.fhir.uv.genomics-reporting | evidence-level-example-vs | Evidence Level Examples | informative | cg | 2025-06 | fhir | |
| HIE2.packages | results-radiology-numobs-gps-dicom-uv-ips | Results Radiology Measurement Observation (GPS-DICOM) - IPS | active | 2022-01 | sct dcm | ||
| hl7.fhir.uv.ips | results-radiology-numobs-uv-ips | Results Radiology Measurement Observation - IPS | trial-use | 2 | pc | 2025-08 | sct loinc dcm |
| hl7.fhir.uv.crmi | artifact-resource-types | Artifact Resource Types | trial-use | 4 | cds | 2025-08 | fhir |
| hl7.fhir.uv.sdc | keyboardType | Questionnaire Item Keyboard Type | trial-use | 4 | fhir | 2025-08 | fhir |
| hl7.fhir.uv.cql | publishable-example | Example Danger signs Codes Grouper | draft | 2023-07 | fhir | ||
| hl7.fhir.uv.crmi | computable-example | Danger signs Codes Grouper (Computable Example) | draft | 2023-07 | fhir | ||
| hl7.fhir.uv.crmi | expanded-example | Danger signs Codes Grouper (Expanded Example) | draft | 2023-07 | |||
| hl7.fhir.uv.crmi | publishable-example | Danger signs Codes Grouper (Publishable Example) | draft | 2023-07 | fhir | ||
| hl7.fhir.uv.genomics-reporting | hgvs-vs | Human Genome Variation Society (HGVS) Nomenclature | trial-use | 2 | cg | 2025-06 | gene |
| hl7.fhir.uv.ips | current-smoking-status-uv-ips | Current Smoking Status - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.phenomics-exchange | HistologicalDiagnosis | HistologicalDiagnosis | draft | cic | 2020-02 | ncit | |
| hl7.fhir.uv.phenomics-exchange | PhenotypicModifierValueSet | Phenotypic modifier ValueSet | draft | cic | 2024-06 | gene | |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.3--20240802092105 | IPS Allergy Reaction | draft | 2024-08 | sct | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.42--20170524000000 | IPS Allergy Status Code | draft | 2024-08 | fhir | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.62--20180207120421 | IPS Allergy Verification Status | draft | 2024-08 | fhir | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.10--20240802091633 | IPS Allergy or Intolerance Conditions | draft | 2024-08 | sct | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.65--20240802091315 | IPS Allergy or Intolerance Substances | draft | 2024-08 | sct | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.8--20170329000000 | IPS Condition Verification Status | draft | 2024-08 | fhir | ||
| hl7.fhir.uv.ips | diagnostics-report-status-uv-ips | Diagnostics Report Status Codes - IPS | trial-use | 2 | pc | 2025-08 | fhir |
| hl7.fhir.uv.ips | edd-method-uv-ips | Pregnancy Expected Delivery Date Method - IPS | trial-use | 2 | pc | 2025-08 | loinc |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.72--20240802094107 | IPS Pregnancy Expected Delivery Date Method | draft | 2024-08 | loinc | ||
| hl7.fhir.uv.ips | healthcare-professional-roles-uv-ips | Healthcare Professional Roles - IPS | trial-use | 2 | pc | 2025-08 | oid |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.53--20170621000000 | IPS Healthcare Professional Roles | draft | 2024-08 | oid | ||
| hl7.fhir.uv.ips | imaging-study-status-uv-ips | Imaging Study Status Codes - IPS | trial-use | 2 | pc | 2025-08 | fhir |
| hl7.fhir.uv.ips | medical-devices-uv-ips | Medical Devices - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.71--20240802094107 | IPS Medications Products | draft | 2024-08 | sct | ||
| hl7.fhir.uv.ips | medication-uv-ips | Medications - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.ips | medicine-active-substances-uv-ips | Medicine Active Substances - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.ips | results-status-uv-ips | Results Status Codes - IPS | trial-use | 2 | pc | 2025-08 | fhir |
| HIE2.packages | result-coded-value-pathology-gps-uv-ips | Results Coded Values Pathology (GPS) - IPS | active | 2022-01 | sct | ||
| hl7.fhir.uv.ips | pregnancies-summary-uv-ips | Pregnancy Outcome - IPS | trial-use | 2 | pc | 2025-08 | loinc |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.21--20170413000000 | IPS Pregnancies Summary | draft | 2024-08 | loinc | ||
| hl7.fhir.uv.ips | problems-uv-ips | Problems - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.73--20240802094107 | IPS Problems | draft | 2024-08 | sct | ||
| hl7.fhir.uv.ips | procedures-uv-ips | Procedures - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.ips | results-coded-values-laboratory-pathology-uv-ips | Results Coded Values Laboratory/Pathology - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.38--20170523000000 | IPS Results Observation | draft | 2024-08 | loinc | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.37--20170523000000 | IPS Results Organizer | draft | 2024-08 | loinc | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.66--20240802105026 | IPS Results Radiology Textual Observations | draft | 2024-08 | sct loinc dcm | ||
| HIE2.packages | results-radiology-txtobs-gps-dicom-loinc-uv-ips | Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS | active | 2022-01 | sct loinc dcm | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.76--20240802105320 | IPS Results Specimen Collection Method | draft | 2024-08 | sct | ||
| HIE2.packages | results-specimen-collection-method-gps-uv-ips | Results Specimen Collection Method (GPS) - IPS | active | 2022-01 | sct | ||
| HIE2.packages | results-specimen-type-gps-uv-ips | Results Specimen Type (GPS) - IPS | active | 2022-01 | sct | ||
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.56--20240802105507 | IPS Specimen Type | draft | 2024-08 | sct | ||
| hl7.fhir.uv.ips | results-specimen-type-uv-ips | Results Specimen Type - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.ips | results-specimen-collection-method-uv-ips | Results Specimen Collection Method - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.ips | vaccines-uv-ips | Vaccines - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.ips | vaccines-whoatc-uv-ips | Vaccines WHO ATC - IPS | trial-use | 2 | pc | 2025-08 | atc |
| hl7.fhir.uv.ips | target-diseases-uv-ips | Vaccine Target Diseases - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.ips | allergies-intolerances-uv-ips | Allergies & Intolerances - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.ips | allergy-reaction-uv-ips | Allergy Reaction - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.cda.uv.ips | 2.16.840.1.113883.11.22.55--20240802093131 | IPS Body Site | draft | 2024-08 | sct | ||
| hl7.fhir.uv.ips | body-site-uv-ips | Body Site - IPS | trial-use | 2 | pc | 2025-08 | sct |
| hl7.fhir.uv.ips | pregnancy-status-uv-ips | Pregnancy Status - IPS | trial-use | 2 | pc | 2025-08 | sct |
FHIR